Novel Immunotherapy Approach Enhances Immune Surveillance in Gliomas
Novel Immunotherapy Approach Enhances Immune Surveillance in Gliomas https://pediatricsnationwide.org/wp-content/uploads/2021/01/AdobeStock_82959563_brain-imaging-for-web-1024x575.gif 1024 575 Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gif
Genetically engineered myeloid cells release interleukin-2, which helps the immune system overcome the immunosuppressive tumor microenvironment in gliomas. Gliomas — tumors originating from the neuronal support (glial) cells of the central nervous system — are one of the leading causes of cancer-related death in adolescents and young adults. Approximately two-thirds of gliomas in these…